3SBio data files APX001 IND application with SFDA in China Apexigen.

3SBio data files APX001 IND application with SFDA in China Apexigen, Inc How much is Famvir? ., an emerging biopharmaceutical company focused on the discovery and development of monoclonal antibody therapeutics, today that it is partner announced, 3SBio [SSRX] of Shenyang, China, filed an Investigational New Drug program for APX001, also known as SSS07, with the State Food and Medication Administration in China. Upon approval of the IND, APX001/SSS07 shall be studied in clinical trials for the treatment of autoimmune and inflammatory diseases.

They then decided to use a specialized MRI that captured even more data to be able to build a model of the fetus’s encounter with a 3D printer. The 3D model predicted a cleft lip and a cleft palate without airway obstruction. Thompson could safely deliver her son. ‘By doing the 3D modeling, we were able to tell that the mass wasn’t cancerous and identified that it might be safe to not do the most advanced types of intervention,’ Dr. Glenn Green, Associate Professor of Pediatric Otolaryngology at Mott Children’s, informed CBS News.